ARTICLE | Finance
Inhibrx, Harmony debut on NASDAQ as JW, Harbour line up on HKEX
August 20, 2020 1:34 AM UTC
Investor appetite for biotech is going strong in both the U.S. and Hong Kong, with Inhibrx and Harmony posting double-digit gains Wednesday after pricing upsized NASDAQ IPOs late Tuesday, and JW and Harbour lining up for public debuts on the Hong Kong stock exchange.
Harmony Biosciences Holdings Inc. (NASDAQ:HRMY) had the largest stock move of the two new listings, adding $13.01 (54%) to $37.01 and closing Wednesday with a market cap of $2.4 billion...